Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Merck
Citi
Boehringer Ingelheim
Chubb
Julphar
Cerilliant
Farmers Insurance
Cipla
Argus Health
Queensland Health

Generated: October 19, 2017

Patent: ► Subscribe

Summary for Patent: ► Subscribe

Title:Potency assays for antibody drug substance binding to an Fc receptor
Abstract: The invention relates to a method of characterizing an antibody, which method is suitable as a potency assay for batch release of a pharmaceutical composition comprising an antibody, specifically for use when applying for marketing authorization for said pharmaceutical composition. The assay provided is a method for determining the potency of a drug product comprising an FcR binding peptide, wherein at least one mechanism of action of the FcR binding peptide of the drug product is mediated through the binding of the FcR binding peptide of the drug product to a Fc receptor, wherein said method comprises determining the binding of the FcR binding peptide of the drug product to an Fc receptor.
Inventor(s): Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL)
Assignee: GENMAB A/S (Copenhagen, DK)
Application Number:11/989,064
Patent Claim Types:
see list of patent claims
Use; Formulation;

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Inventors Patent Expiration Status Orphan Source
Biogen
ZINBRYTA
daclizumab
INJECTABLE;INJECTION7610290012016-05-27► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXsearch
Genentech
PERJETA
pertuzumab
VIAL; SINGLE-USE1254090012012-06-08► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXsearch
Bristol Myers Squibb
YERVOY
ipilimumab
INJECTABLE; INJECTION1253770012011-03-25► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXsearch
Glaxo Grp Ltd
ARZERRA
ofatumumab
INJECTABLE; INJECTION1253260012009-10-26► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXsearch
Genentech
AVASTIN
bevacizumab
VIAL; INTRAVENOUS1250850022004-02-26► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXsearch
Genentech
AVASTIN
bevacizumab
VIAL; INTRAVENOUS1250850012004-02-26► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXsearch
Imclone
ERBITUX
cetuximab
VIAL; INTRAVENOUS1250840012004-06-18► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXOrphansearch
Abbvie Inc
HUMIRA
adalimumab
VIAL1250570022002-12-31► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXsearch
Abbvie Inc
HUMIRA
adalimumab
SYRINGE1250570012002-12-31► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXsearch
Spectrum Pharms
ZEVALIN
ibritumomab tiuxetan
INJECTABLE; INJECTION1250190012002-02-19► Subscribe GENMAB A/S (Copenhagen, DK) Gerarda Havenith; Catharina Emanuele (Bodegraven, NL), Vink; Tom (Alphen aan den Rijn, NL), Berkel; Patrick Van (Utrecht, NL), Parren; Paul (Odijk, NL) ► SubscribeRXOrphansearch
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Summary for Patent: ► Subscribe

PCT Information
PCT FiledJuly 21, 2006PCT Application Number:PCT/DK2006/000426
PCT Publication Date:January 25, 2007PCT Publication Number: WO2007/009469

International Patent Family for Patent: ► Subscribe

Country Document Number Publication Date
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

US Army
McKesson
Julphar
Baxter
UBS
Teva
Argus Health
Dow
US Department of Justice
Chubb

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot